drug
as of 2026-07-01Gabapentin
MeSH D000077206
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hannover Medical School
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
SchizophreniaDepressionPsychosomatic DisordersBipolar DisorderCannabis Use Disorder, ModerateSchizophreniaAnxiety DisordersCannabis Use Disorder, SevereDepressionCannabis Use Disorder, MildBipolar II DisorderCannabis UseLymphoma, FollicularBipolar DisorderPsychotic DisordersPsychophysiologic Disorders
Trials
2
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
NCT05064319Phase 2Recruiting
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication
KOL
Helge Frieling, Prof., MD
personKOL score 5
James J Prisciandaro, PhD
personKOL score —